ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EG02 | G | Everolimus - 5mg | 11381 | 113121/1 | EVEROLIMUS BIOGARAN | 5mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | 89,386,347 L.L | 2.44 | E2 | Laboratoires Biogaran | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EG02 | B | Everolimus - 5mg | 5897 | 218674/10 | AFINITOR | 5mg | 30 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 137,514,843 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
L01EG02 | G | Everolimus - 5mg | 10482 | 2320/1 | EVEROLIMUS ARROW | 5mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | 68,310,601 L.L | 10.71 | E1 | Arrow Génériques | France | 2/5/2024 | 0 |
L01EG02 | G | Everolimus - 5mg | 11381/388 | 113121/1 | EVEROLIMUS BIOGARAN | 5mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | L.L | 2.44 | E2 | Laboratoires Biogaran | France | 2/5/2024 |